Holen Sie sich die Stockscreener-App
15.58
0.52%
0.08
Handel nachbörslich:
15.34
-0.24
-1.54%
Schlusskurs vom Vortag:
$15.50
Offen:
$15.24
24-Stunden-Volumen:
1.21M
Relative Volume:
0.63
Marktkapitalisierung:
$2.37B
Einnahmen:
$177.28M
Nettoeinkommen (Verlust:
$-195.24M
KGV:
-11.63
EPS:
-1.34
Netto-Cashflow:
$-114.54M
1W Leistung:
+8.57%
1M Leistung:
+23.55%
6M Leistung:
+99.23%
1J Leistung:
+214.75%
1-Tages-Spanne:
$15.21
$15.78
1-Wochen-Bereich:
$14.39
$15.94
52-Wochen-Spanne:
$4.27
$15.94
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
15.58 | 2.31B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Guggenheim | Buy |
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 52-Week High After Analyst Upgrade - Defense World
Is Adaptive Biotechnologies Corporation stock entering bullish territoryPortfolio Risk Summary & Verified Entry Point Signals - newser.com
JP Morgan Raises Price Target for Adaptive Biotechnologies (ADPT) to $17.00 | ADPT Stock News - GuruFocus
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
How Adaptive Biotechnologies Corporation stock trades during market volatilityJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.57 - Markets Mojo
Is Adaptive Biotechnologies Corporation stock near bottom after declineEarnings Recap Report & Free High Return Stock Watch Alerts - newser.com
Adaptive Biotechnologies Hits Day High with 8.36% Surge in Stock Price - Markets Mojo
Risk vs reward if holding onto Adaptive Biotechnologies CorporationLong Setup & Risk Controlled Daily Trade Plans - newser.com
Will Adaptive Biotechnologies Corporation bounce back from current support2025 Short Interest & Target Return Focused Stock Picks - newser.com
Adaptive Biotechnologies stock hits 52-week high at $15.29 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $15.29 - Investing.com
Adaptive Biotechnologies (ADPT): A Fresh Analyst Spotlight Prompts a Closer Look at Valuation and Growth Potential - simplywall.st
What technical signals suggest for Adaptive Biotechnologies Corporation stockJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
Can volume confirm reversal in Adaptive Biotechnologies CorporationJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Why analysts upgrade Adaptive Biotechnologies Corporation stock2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock bottoming after sell offJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Adaptive Biotechnologies Corporation trending in predictive chart modelsQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
What recovery options are there for Adaptive Biotechnologies CorporationJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
Why Adaptive Biotechnologies (ADPT) Is Up 8.5% After clonoSEQ’s Integration With Flatiron Health’s OncoEMR - simplywall.st
Is Adaptive Biotechnologies Corporation stock poised for growthJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Adaptive Biotechnologies Corporation stock momentum explainedJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.26 - Markets Mojo
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Adaptive Biotechnologies Corp. Hits New 52-Week High at $15.04 - Markets Mojo
Adaptive Biotechnologies Hits Day High with 13.94% Surge in Stock Price - Markets Mojo
Adaptive Biotechnologies stock hits 52-week high at $14.49 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Now Covered by Analysts at Guggenheim - Defense World
A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts - Benzinga
Guggenheim Initiates Coverage on ADPT with 'Buy' Rating | ADPT S - GuruFocus
Adaptive Biotechnologies stock hits 52-week high at $14.49 - Investing.com
Guggenheim Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $20 - 富途牛牛
Will Adaptive Biotechnologies Corporation (1HM) stock gain from lower interest ratesWeekly Investment Summary & Free Real-Time Volume Trigger Notifications - newser.com
Real time alert setup for Adaptive Biotechnologies Corporation performanceWeekly Risk Summary & Step-by-Step Trade Execution Guides - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock dividend growth reliableCEO Change & Entry Point Strategy Guides - newser.com
Adaptive Biotechnologies Corporation stock outlook for YEARSwing Trade & Safe Swing Trade Setups - newser.com
The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook - Yahoo Finance
Adaptive Biotechnologies (ADPT): Exploring Valuation After Recent Share Price Momentum - Yahoo Finance
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):